805 related articles for article (PubMed ID: 18195197)
1. Risk of thromboembolism with short-term interruption of warfarin therapy.
Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
3. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
[TBL] [Abstract][Full Text] [Related]
4. Therapy Insight: management of urology patients taking long-term warfarin anticoagulation therapy.
Daniels PR
Nat Clin Pract Urol; 2005 Jul; 2(7):343-50. PubMed ID: 16474787
[TBL] [Abstract][Full Text] [Related]
5. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
6. Periprocedural management of anticoagulation in patients on extended warfarin therapy.
Jafri SM; Mehta TP
Semin Thromb Hemost; 2004 Dec; 30(6):657-64. PubMed ID: 15630672
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin as bridging therapy during interruption of oral anticoagulation in patients undergoing colonoscopy or gastroscopy.
Constans M; Santamaria A; Mateo J; Pujol N; Souto JC; Fontcuberta J
Int J Clin Pract; 2007 Feb; 61(2):212-7. PubMed ID: 17263709
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
[TBL] [Abstract][Full Text] [Related]
9. Perioperative management of long-term anticoagulation.
Kearon C
Semin Thromb Hemost; 1998; 24 Suppl 1():77-83. PubMed ID: 9840696
[TBL] [Abstract][Full Text] [Related]
10. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
11. Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery.
Douketis JD; Woods K; Foster GA; Crowther MA
Thromb Haemost; 2005 Sep; 94(3):528-31. PubMed ID: 16268467
[TBL] [Abstract][Full Text] [Related]
12. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
Abdelhafiz AH; Wheeldon NM
Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
[TBL] [Abstract][Full Text] [Related]
14. Oral surgery in patients on anticoagulant treatment without therapy interruption.
Ferrieri GB; Castiglioni S; Carmagnola D; Cargnel M; Strohmenger L; Abati S
J Oral Maxillofac Surg; 2007 Jun; 65(6):1149-54. PubMed ID: 17517299
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy.
Varkarakis IM; Rais-Bahrami S; Allaf ME; Lima GC; Permpongkosol S; Rao P; Jarrett TW; Kavoussi LR
J Urol; 2005 Sep; 174(3):1020-3; discussion 1023. PubMed ID: 16094036
[TBL] [Abstract][Full Text] [Related]
16. Outpatient management of anticoagulation therapy.
du Breuil AL; Umland EM
Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618
[TBL] [Abstract][Full Text] [Related]
17. Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.
Middlekauff HR; Stevenson WG; Gornbein JA
Arch Intern Med; 1995 May; 155(9):913-20. PubMed ID: 7726699
[TBL] [Abstract][Full Text] [Related]
18. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
[TBL] [Abstract][Full Text] [Related]
19. The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic cardiac valve replacement.
Stewart S; Cianciotta D; Alexson C; Manning J
J Thorac Cardiovasc Surg; 1987 Apr; 93(4):551-4. PubMed ID: 3561002
[TBL] [Abstract][Full Text] [Related]
20. Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation.
Boulanger L; Hauch O; Friedman M; Foster T; Dixon D; Wygant G; Menzin J
Ann Pharmacother; 2006 Jun; 40(6):1024-9. PubMed ID: 16735649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
